Moleculin Biotech, Inc.
MBRX
$0.9502
$0.07538.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M |
| Total Depreciation and Amortization | 31.00K | 32.00K | 31.00K | 32.00K | 35.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.28M | 3.92M | -1.24M | -854.00K | 2.12M |
| Change in Net Operating Assets | 1.05M | 528.00K | -418.00K | -925.00K | 3.21M |
| Cash from Operations | -5.08M | -6.11M | -5.95M | -6.72M | -4.90M |
| Capital Expenditure | 0.00 | 0.00 | -13.00K | -- | -81.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -13.00K | -- | -81.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 4.66M | -- | -- | 3.96M |
| Repurchase of Common Stock | 0.00 | -1.00K | -25.00K | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.00K | 4.66M | -25.00K | -- | 3.96M |
| Foreign Exchange rate Adjustments | -45.00K | 14.00K | 8.00K | -9.00K | -6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.13M | -1.44M | -5.98M | -6.73M | -1.03M |